Omneity® Pellets
All-In-One Vitamin & Mineral Pellet
Topic:Disease Prevention
Disease prevention in horses encompasses strategies and practices aimed at minimizing the occurrence and spread of infectious and non-infectious diseases within equine populations. These practices include vaccination programs, biosecurity measures, and regular health monitoring. Vaccination helps to stimulate the horse's immune system to protect against specific pathogens, while biosecurity measures, such as quarantine and sanitation, reduce the risk of disease transmission. Regular health monitoring, including physical examinations and diagnostic testing, aids in early detection and management of potential health issues. This page compiles peer-reviewed research studies and scholarly articles that explore various methods and their effectiveness in preventing diseases in horses, as well as the development and implementation of prevention programs in different equine settings.
A three-year evaluation of four commercial equine influenza vaccines in ponies maintained in isolation. Ponies held in isolation for 40 months were vaccinated and revaccinated with four commercial equine influenza vaccines. Little or no HI antibody was detected after the first inoculation; second and subsequent annual revaccinations produced peak HI antibody titres between 7 and 14 days. Titres fell quickly between 14 and 28 days and less quickly thereafter. The decline of HI antibody appeared to be related more to the initial titre attained and to the period after vaccination than to the composition of the vaccine. The response to a first annual revaccination was superior to that produced by a ...
The outbreak of equine influenza in England: January 1976. Equine influenza type 2 infections occurred in the Newmarket areas in January 1976. The disease did not spread to any extent and while this may have been due to recent vaccination it was found that not all vaccinated horses were fully protected. The virus involved showed some antigenic drift from the prototype strain A/equine/Miami/1/63 (Heq 2 Neq 2).
Regulatory veterinary medicine in a changing environment. There is an increasing need for the veterinary profession to meet the new challenges brought about by increased and intensified livestock production. These challenges consist of control and eradication of diseases, the humane treatment of animals and the prevention of transmission of disease from animals or animal products to man. Examples are given of the contribution which regulatory medicine activities have made to the prevention/control/eradication of screw worm, foot-and-mouth disease, Venezuelan equine encephalomyelitis, Newcastle disease, bovine brucellosis, hog cholera, and certain oth...
Equine degenerative myeloencephalopathy. Five horses of mixed breeding and 1 zebra with symmetric tetraparesis and ataxia were studied. There were 2 females and 4 males. Signs of illness were first noticed from birth to 12 months of age. Clinical and pathologic studies were performed when the animals were 4 to 24 months old. Two of the horses were related. All of the subjects had diffuse degenerative myeloencephalopathy. The degeneration was most pronounced in thoracic segments of the spinal cord. Ventral and dorsolateral funiculi were most severely affected. Axonal swelling and abnormal neuronal cell bodies were seen in the gray mat...
Coughing in horses–an historical aspect. A brief historical review is given of the incidence and types of respiratory disease that occurred in Britain in the 18th and 19th centuries. The significance of poor stabling and overcrowding in the causation and spread of coughing is emphasised and its dramatic reduction by simple methods of hygiene and ventilation.
Epidemiological features of the mycotoxicoses. Although mycotoxicoses attract more and more attention, the epidemiology of these diseases is still not adequately studied. The author devotes his study to certain diseases. In addition to the diseases whose mycotoxic nature is in no doubt, he conditionally includes certain diseases whose mycotoxic causation needs further proof. The author has assigned stachybotryotoxicosis and alimentary toxic aleukia or fusariotoxicosis to the first category and endemic nephropathy and primary liver-cell carcinoma to the second. His intention in adopting this approach is to establish the common features and ...
Chronic bronchitis and alveolar emphysema in the horse. Broken wind is a syndrome characterised by chronic bronchitis and alveolar emphysema. Clinical signs include nasal catarrh, persistent coughing, dyspnoea and poor exercise tolerance. In racehorses, lung haemorrhages may result in epistaxis. Broken wind is a disease of domestication ascribed to pollution of the stable air with fungal spores from hay and straw. Treatment and prevention are based on the provision of fresh air and, if housing is unavoidable, the adoption of a permanent regime of dust-free stable management. If an early diagnosis is made and appropriate treatment instituted, the pr...
The role of wild animals in the spread of exotic diseases in Australia. The distributions of the following feral animals are given -- cattle, buffalo, pig, goat, deer, camel, horse, donkey, fox, dog and cat -- and the native dingo. The possible role these and the native rodents, marsupials and monotremes would play should an exotic disease of livestock enter Australia is discussed. It is considered that feral animals would be important in creating foci from which the disease would spread.
[Influenza vaccination: which vaccine (author’s transl)]. A comparative study of the literature of the past ten years showed that vaccination of horses and ponies against influenza is best done using adjuvant-containing vaccines. Comparable results may probably be obtained by twice inoculating an aquenous vaccine. There are no drawbacks to the use of aluminium-hydroxide as an adjuvant when mineral oil is used as an adjuvant, the first and second vaccinations do not present any problems.
The selection of antibiotics. The usefulness of an antibiotic depends not only upon its antibacterial potency and spectrum but also on the prevalence of resistant organisms and the extent and severity of the adverse reactions to which it may give rise. Variations in formulation of the same compound are reflected in differences in bioavailability. These may be intentional, as in the development of long-acting preparations, but may also be unexpected following differences in drug purity, content and gastro-intestinal absorption. Individual and species differences in treated animals also result in variations in bioavailabilit...
